VA Disability for Chronic Fatigue Syndrome: ME/CFS Rating Under DC 6354 (2026)

What Chronic Fatigue Syndrome Is

Chronic fatigue syndrome is a complex, multisystem illness characterized by profound, persistent fatigue that is not relieved by rest and that substantially limits the patient's pre-illness level of activity. The term myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is used interchangeably; in 2015 the Institute of Medicine proposed systemic exertion intolerance disease (SEID) as a new name to emphasize the central feature of post-exertional malaise.

CFS is a clinical diagnosis. There is no single laboratory test that confirms it. The diagnosis is made by characterizing the symptom pattern, documenting the duration and severity, and excluding alternative explanations for chronic fatigue. The pathophysiology is still being elucidated but involves neuroinflammation, autonomic dysregulation, mitochondrial dysfunction, and HPA axis abnormalities.

Current Diagnostic Criteria

Several diagnostic frameworks are used in clinical practice. The VA does not mandate a specific framework but generally accepts diagnoses made under any recognized set of criteria.

Institute of Medicine (IOM) 2015 / SEID Criteria

The IOM 2015 criteria simplified the diagnosis. Required features are: (1) substantial reduction or impairment in the ability to engage in pre-illness levels of occupational, educational, social, or personal activities for more than 6 months, accompanied by fatigue that is profound, of new or definite onset, not the result of ongoing excessive exertion, and not substantially alleviated by rest; (2) post-exertional malaise; (3) unrefreshing sleep. Plus at least one of: cognitive impairment OR orthostatic intolerance.

Canadian Consensus Criteria

The Canadian Consensus Criteria require fatigue, post-exertional malaise, sleep dysfunction, pain, neurological/cognitive manifestations, and at least one symptom from two of the categories of autonomic, neuroendocrine, and immune manifestations.

Original CDC (Fukuda) Criteria

The 1994 CDC criteria require clinically evaluated unexplained chronic fatigue persisting at least 6 months that significantly reduces activity levels, plus four or more of: impaired memory or concentration, sore throat, tender cervical or axillary lymph nodes, muscle pain, multi-joint pain, new headaches, unrefreshing sleep, and post-exertional malaise.

The Core Clinical Features

Three features are universally recognized across diagnostic frameworks.

Profound, Disabling Fatigue

The fatigue is qualitatively different from normal tiredness. It is profound, persistent, not relieved by rest, and substantially impairs the patient's previous activity level. The fatigue must be new or have a definite onset (not lifelong) and must not be the result of ongoing excessive exertion.

Post-Exertional Malaise (PEM)

PEM is the cardinal feature distinguishing CFS from other fatigue conditions. After physical, cognitive, or emotional exertion, symptoms worsen — often hours to days after the exertion — and the worsening can last days, weeks, or longer. PEM is highly specific to ME/CFS and is essential to the diagnosis.

Unrefreshing Sleep

Despite adequate or even prolonged sleep, patients do not feel refreshed. Sleep architecture is often abnormal on polysomnography, with reduced slow-wave sleep and other findings.

Cognitive Impairment ("Brain Fog")

Slowed information processing, difficulty with concentration and word-finding, impaired working memory. Cognitive symptoms typically worsen with PEM episodes.

Orthostatic Intolerance

Symptoms of dizziness, lightheadedness, palpitations, or fatigue worsening upon standing, often with measurable heart rate or blood pressure changes (postural orthostatic tachycardia syndrome, neurally mediated hypotension).

Additional Symptoms

Pain (myalgia, arthralgia, headache), tender lymph nodes, sore throat, immune symptoms, and autonomic symptoms (gastrointestinal, thermoregulatory, urinary) are common but not all are required by every diagnostic framework.

Diagnostic Workup and Exclusion

CFS is a diagnosis of exclusion. Before the diagnosis can be made, alternative explanations for chronic fatigue must be evaluated and ruled out.

Routine Laboratory Workup

Complete blood count, comprehensive metabolic panel, thyroid function tests, urinalysis, inflammatory markers (ESR, CRP), creatine kinase, and sometimes celiac serologies and vitamin levels. Specific testing is guided by the clinical picture.

Excluded Diagnoses

Alternative diagnoses that must be considered and ruled out include hypothyroidism, anemia, diabetes, adrenal insufficiency, sleep apnea, depression, inflammatory bowel disease, autoimmune disease, occult malignancy, and other causes of chronic fatigue.

Co-Occurring vs. Excluding Conditions

Some conditions commonly co-occur with CFS (fibromyalgia, postural orthostatic tachycardia syndrome, irritable bowel syndrome) rather than excluding the diagnosis. Other conditions, when they are the primary cause of fatigue, exclude the CFS diagnosis.

Rating Under DC 6354

Chronic fatigue syndrome is rated under 38 CFR 4.88b, Diagnostic Code 6354.

100 Percent

Symptoms which are nearly constant and so severe as to restrict routine daily activities almost completely and which may occasionally preclude self-care.

60 Percent

Symptoms which are nearly constant and restrict routine daily activities to less than 50 percent of the pre-illness level, OR symptoms that wax and wane, resulting in periods of incapacitation of at least six weeks total duration per year.

40 Percent

Symptoms which are nearly constant and restrict routine daily activities to 50 to 75 percent of the pre-illness level, OR symptoms that wax and wane resulting in periods of incapacitation of at least four but less than six weeks total duration per year.

20 Percent

Symptoms which are nearly constant and restrict routine daily activities by less than 25 percent of the pre-illness level, OR symptoms that wax and wane resulting in periods of incapacitation of at least two but less than four weeks total duration per year.

10 Percent

Symptoms which wax and wane but result in periods of incapacitation of at least one but less than two weeks total duration per year, OR symptoms controlled by continuous medication.

Severity Tiers Explained

The DC 6354 rating analysis emphasizes two parallel pathways: (1) the constancy and severity of symptoms relative to pre-illness baseline, and (2) the cumulative duration of periods of incapacitation over the past 12 months.

Restriction of Pre-Illness Activity Level

This pathway asks: how much of the veteran's pre-illness activity level can they currently sustain? A veteran who could previously work full-time, exercise regularly, and maintain social/family responsibilities, but now manages only 25 percent of those activities, would generally support the 60 percent rating tier under the "less than 50 percent of pre-illness level" criterion.

Periods of Incapacitation

This pathway counts cumulative time during the year when the veteran was so impaired that they could not work or perform routine activities. Six weeks total per year supports the 60 percent tier; four to six weeks supports the 40 percent tier; two to four weeks supports the 20 percent tier.

Documentation Matters

Both pathways require documentation. Treatment records, activity logs, missed work documentation, and statements from family members supporting the level of impairment all contribute. A symptom and activity diary is one of the most useful pieces of evidence for the rating analysis.

Gulf War Presumptive Service Connection

Under 38 CFR 3.317, chronic fatigue syndrome is specifically named as a presumptive medically unexplained chronic multisymptom illness for veterans who served in the Southwest Asia theater of operations.

Qualifying Service

Service in the Persian Gulf, Iraq, Kuwait, Saudi Arabia, Bahrain, Qatar, United Arab Emirates, Oman, the Gulf of Aden, Gulf of Oman, Red Sea, Arabian Sea, and surrounding waters and airspace. Service in Afghanistan, Syria, Djibouti, Lebanon, Egypt, Jordan, Turkey, Yemen, and Uzbekistan also qualifies under recent expansions.

Time Frame for Manifestation

The presumption applies to chronic disabilities manifesting to a compensable degree (10 percent or more) by an established time frame, which has been extended multiple times by Congress. As of 2026, qualifying chronic disabilities must manifest by December 31, 2031.

Effect on the Claim

Presumptive service connection removes the requirement to demonstrate a specific in-service event or medical nexus. The veteran must still document the diagnosis and severity, but the connection to service is legally presumed.

Non-Gulf War Veterans

Veterans without qualifying Southwest Asia service can still pursue direct service connection for CFS by establishing the diagnosis, an in-service event or exposure, and a medical nexus opinion. Secondary service connection may also apply when CFS develops in the setting of a service-connected condition.

Evidence That Strengthens a CFS Claim

A defensible CFS claim typically rests on the following evidence.

Specialist Diagnosis

Diagnosis from an internal medicine physician, rheumatologist, infectious disease specialist, or other clinician familiar with CFS diagnostic criteria. The diagnostic framework used (IOM 2015, Canadian Consensus, CDC) should be identified.

Comprehensive Laboratory Workup

Documentation that alternative explanations for chronic fatigue have been evaluated and ruled out.

Symptom and Activity Documentation

A symptom diary, activity log, or pacing journal showing the day-by-day pattern of fatigue, PEM episodes, and functional capacity. These records are particularly useful for the DC 6354 rating analysis.

Pre-Illness Activity Baseline

Documentation of the veteran's pre-illness activity level — employment history, exercise routine, household responsibilities, social engagement — provides the baseline against which current impairment is measured.

Treatment Records

Records of pharmacologic trials (low-dose stimulants, autonomic-acting medications, sleep medications), non-pharmacologic interventions (pacing, graded activity, cognitive behavioral approaches), and treatment response.

Functional Documentation

Statements from family members, employers (or former employers), and others describing the impact of CFS on daily functioning.

Service Documentation

For Gulf War presumptive claims, deployment records and DD-214 establishing qualifying service in the Southwest Asia theater. For direct service connection, service treatment records or evidence of an in-service trigger.

Related Conditions and Overlap

CFS frequently co-occurs with several related conditions. Co-occurrence does not preclude separate service connection and rating for each condition when independently diagnosed.

Fibromyalgia

Fibromyalgia (rated under DC 5025) and CFS share central sensitization mechanisms and frequently overlap. Both can be separately diagnosed and rated when the clinical pictures meet each set of criteria.

Postural Orthostatic Tachycardia Syndrome (POTS)

POTS frequently co-occurs with CFS. Orthostatic intolerance is one diagnostic criterion for CFS but may also be evaluated as a separate cardiovascular condition.

Irritable Bowel Syndrome

IBS frequently co-occurs with CFS. IBS is rated separately under DC 7319.

Mental Health Conditions

Depression and anxiety frequently co-occur with CFS. When independently diagnosed under DSM-5 criteria and service-connected, they are rated separately under 38 CFR 4.130.